Immix Biopharma, Inc. IMMX

$IMMX B of A Securities Initiates Coverage On Immix Biopharma with Buy Rating, Announces Price Target of $27
B of A Securities analyst Tazeen Ahmad initiates coverage on Immix Biopharma (NASDAQ:IMMX) with a Buy rating and announces Price Target of $27.

IMMX B of A Securities Initiates Coverage On Immix Biopharma with Buy Rating, Announces Price Target of $27
B of A Securities analyst Tazeen Ahmad initiates coverage on Immix Biopharma (NASDAQ:IMMX) with a Buy rating and announces Price Target of $27.

Reverse head and shoulders on the three month ?

Obviously this stock is dead

Every stock been down for over a week u tell me mm’s aren’t ruining markets the shorting shit gta stop too everyone pulling there money out finally

Shouldn’t we have been short selling restricted today

If u don’t wanna lose everything get your money out now right now

Going under 3$ today

This stock is finished I knew it was bad results

This is tanking cause negative results got out early